Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Jun 2020 09:00 AM
RNS
Price Monitoring Extension
18 Jun 2020 07:00 AM
RNS
PDS & Farmacore Announce Co-Development-PDS0204
15 Jun 2020 02:41 PM
RNS
PDS Announces Initiation of Phase 2 Trial PDS0101
08 Jun 2020 04:42 PM
RNS
Second Price Monitoring Extn
08 Jun 2020 04:36 PM
RNS
Price Monitoring Extension
05 Jun 2020 09:14 AM
RNS
PDS Announces Trial of its Lead Product, PDS0101
01 Jun 2020 07:00 AM
RNS
Notice of AGM
13 May 2020 02:46 PM
RNS
PDS Reports Results for Q1 2020 & Business Update
01 May 2020 11:33 AM
RNS
Confirmation of Board Changes
30 Apr 2020 12:06 PM
RNS
PDS expands CRADA with National Cancer Institute
27 Apr 2020 07:00 AM
RNS
Preliminary Results for the year ended 31 Dec 2019
17 Apr 2020 04:40 PM
RNS
Second Price Monitoring Extn
17 Apr 2020 04:36 PM
RNS
Price Monitoring Extension
17 Apr 2020 02:06 PM
RNS
Second Price Monitoring Extn
17 Apr 2020 02:00 PM
RNS
Price Monitoring Extension
16 Apr 2020 04:40 PM
RNS
Second Price Monitoring Extn
16 Apr 2020 04:35 PM
RNS
Price Monitoring Extension
16 Apr 2020 02:02 PM
RNS
PDS Initiates Programs for COVID-19, PDS0101 delay
14 Apr 2020 07:04 AM
RNS
PDS Appoints Ilian Iliev to the Board
31 Mar 2020 07:00 AM
RNS
Board Changes
30 Mar 2020 09:39 AM
RNS
Holding(s) in Company
14 Feb 2020 03:12 PM
RNS
Holding(s) in Company
12 Feb 2020 11:07 AM
RNS
PDS equity issue and related party transaction
11 Feb 2020 02:24 PM
RNS
PDS Biotechnology proposed offering
15 Jan 2020 07:00 AM
RNS
Board Change
18 Dec 2019 11:24 AM
RNS
Holding(s) in Company
17 Dec 2019 03:04 PM
RNS
Holding(s) in Company
13 Dec 2019 01:21 PM
RNS
Board Changes
21 Nov 2019 07:00 AM
RNS
Glycotest receives 2nd $3m tranche of $10m finance
17 Oct 2019 02:14 PM
RNS
Holding(s) in Company
14 Oct 2019 07:00 AM
RNS
Appointment to the Board
03 Oct 2019 01:44 PM
RNS
PDS collaborates with Merck in Phase 2 studies
01 Oct 2019 02:10 PM
RNS
PDS prioritise PDS0101 in high risk HPV to Phase 2
19 Sep 2019 01:24 PM
RNS
PDS - positive data for immunotherapy treatment
19 Sep 2019 11:00 AM
RNS
Interim Results for six months ended 30 June 2019
01 Aug 2019 01:44 PM
RNS
PDS second quarter 2019 financial results
31 Jul 2019 08:41 AM
RNS
PDS Biotechnology Corp liquidity funding program
09 Jul 2019 02:58 PM
RNS
Holding(s) in Company
08 Jul 2019 04:04 PM
RNS
Holding(s) in Company
18 Jun 2019 02:27 PM
RNS
Result of Annual General Meeting
31 May 2019 07:00 AM
RNS
Positive new data demonstrates NEATstiks potential
24 May 2019 09:50 AM
RNS
Notice of AGM and Annual Report & Accounts
22 May 2019 07:00 AM
RNS
Full Year Results for the year ended 31 Dec 2018
16 May 2019 03:07 PM
RNS
PDS Biotechnology journal publication
25 Apr 2019 07:00 AM
RNS
Resignation of CEO
22 Mar 2019 04:42 PM
RNS
Sale of Wanda and Vortex
19 Mar 2019 07:00 AM
RNS
PDS merger with Edge Therapeutics update
18 Mar 2019 02:09 PM
RNS
PDS completes merger with Edge Therapeutics
18 Mar 2019 02:07 PM
RNS
Orderly wind up of Wanda and Vortex
14 Mar 2019 07:00 AM
RNS
Share Price Movement
UK 100

Latest directors dealings